MK-0626 is an orally available dipeptidyl peptidase IV (DPP-4) inhibitor that attenuates hepatic steatosis and accumulation by enhancing AMPK activity.MK-0626 attenuates TAC-induced diabetic pancreatic islet injury by restoring the expression of GLP-1R.MK-0626 is able to increase circulating endothelial progenitor cell numbers and endothelial-type nitric oxide synthase expression by promoting neoangiogenesis.
Molecular Weight:
442.46
Purity:
>99.99%
CAS Number:
[690257-74-0]
Formula:
C22H24F2N6O2
Target:
AMPK|||Glucagon Receptor
T68863
* VAT and and shipping costs not included. Errors and price changes excepted